David Adler

David Adler has extensive work experience in the field of business development, primarily in the healthcare industry. David started their career at GlaxoSmithKline in 1992, where they served as a Sr. Market Development Manager for medical groups until 2009. Following this, they joined McKesson as a Director of Business Development, a role they held from August 2009 to May 2015. David then progressed to the position of Executive Director of Business Development at McKesson's subsidiary, US Oncology Research. In 2021, David joined US ONCOLOGY RESEARCH, LLC as the Vice President of Business Development. Their most recent role is as the Vice President of Business Development at the Sarah Cannon Research Institute, which they assumed in November 2022.

David Adler attended California State University, Northridge from 1982 to 1987. During this time, they obtained a Bachelor of Arts degree in Speech Communications.